Table 1.
Demographic characteristics and diagnoses distribution of healthcare super-utilizers and the control group.
| Super-utilizers | Control | |
|---|---|---|
| Total participants | 109 | 109 |
| Race | ||
| African American | 98 (89%) | 83 (76%) |
| White | 11 (11%) | 23 (21%) |
| Other | 0 | 3 (3%) |
| Females | 90 (83%) | 94 (86%) |
| Age range (yrs) and IQR | [20, 58]; 8 | [20, 84]; 34 |
| Age median (yrs) | 28 | 31 |
| Charlson Comorbidity Score range and IQR | [−16, 57]; 7 | [−9, 28]; 5 |
| Distribution of top diagnoses | ||
| Injury and poisoning | 92 (84%) | 60 (55%) |
| Respiratory symptoms | 81 (74%) | 51 (46%) |
| Skin disorders | 74 (67%) | 45 (41%) |
| Anxiety | 38 (34%) | 15 (13%) |
| Depression | 43 (39%) | 23 (21%) |
| Drug abuse | 21 (19%) | 6 (5%) |
A participant could have multiple documented diagnoses at each visit. Distribution of top diagnoses are significantly different across groups at p < 0.001.